Hans De Reu

Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells

Gils Roex, Diana Campillo-Davó, Donovan Flumens et al. · Journal of Translational Medicine · 2022 · 54 citations · Full text

Life Sciences, Immunology, Oncology +17

Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity

Johan van den Bergh, Yannick Willemen, Eva Lion et al. · Oncotarget · 2015 · 52 citations · Full text

Life Sciences, Cancer Biology, Immunology +17

Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion

Heleen H. Van Acker, Sébastien Anguille, Hans De Reu et al. · Frontiers in Immunology · 2018 · 46 citations · Full text

Life Sciences, Immunology, Oncology +17

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

Diana Campillo-Davó, Fumihiro Fujiki, Johan M.J. Van den Bergh et al. · Frontiers in Immunology · 2018 · 42 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

Johan M.J. Van den Bergh, Evelien Smits, Zwi Berneman et al. · Cancer Immunology Research · 2017 · 41 citations

Medicine, Immunology, Oncology +17